Related Experiment Video
Updated: Mar 12, 2026

11:29
Anteromesial Temporal Lobectomy for Medically Intractable Temporal Lobe Epilepsy: An Operative Study
Published on: August 15, 2025
2.8K
Endoscopic Transorbital Approach for Select Recurrent and Newly Diagnosed Anteromedial Temporal Lobe Gliomas
Jonathan A Tangsrivimol1,2, Nader Delavari2, Kyle J Godfrey3
1Department of Neurosurgery, Chulabhorn Hospital, Bangkok, Thailand.
Journal of Neurological Surgery. Part B, Skull Base
|March 11, 2026
Summary
The endoscopic lateral transorbital approach (eLTOA) is effective for managing medial temporal lobe gliomas, aiding in diagnosis and resection. This minimal access technique shows promise for both recurrent and newly diagnosed tumors.
Area of Science:
- Neurosurgery
- Minimally Invasive Techniques
- Oncology
Background:
- The endoscopic lateral transorbital approach (eLTOA) is a minimal access technique for the middle fossa and periorbital region.
- Its application in managing medial temporal lobe gliomas is explored.
Purpose of the Study:
- To evaluate the applicability of eLTOA in the management of recurrent and newly diagnosed medial temporal lobe gliomas.
- To assess the safety and efficacy of eLTOA for glioma surgery.
Main Methods:
- Retrospective review of 40 patients undergoing eLTOA from 2016-2024.
- Analysis of five glioma cases, including demographic, clinical, radiographic, histopathological, and molecular data.
Main Results:
- eLTOA was used for biopsy and molecular genotyping in four recurrent gliomas and gross total resection (GTR) in one newly diagnosed tumor.
- Histological diagnoses included glioblastoma multiforme, xanthoastrocytoma, and dysembryoplastic neuroepithelial tumor, with one upgrade from Grade II to Grade IV glioma.
- Average length of stay was 3 days with one transient diplopia complication.
Conclusions:
- eLTOA provides a minimally invasive, direct route to medial temporal lobe gliomas.
- It reduces risks associated with reoperation, such as infection and temporalis muscle atrophy.
- eLTOA is valuable for restaging recurrent tumors and achieving GTR in select newly diagnosed cases.

